1-3 of 3
Sheikh Usman Iqbal
Close
Sort by
Journal Articles

Symptom Burden and Health-Related Quality Of Life (HRQoL) In Patients With Myelofibrosis (MF) Treated With Fedratinib (SAR302503) In a Phase III Study (JAKARTA)

Ruben A. Mesa, MD, Jorge E. Cortes, MD, Francisco Cervantes, MD, Donald Milligan, MD, FRCP, FRCPath, Tamás Masszi, MD, PhD, Elena Mishchenko, MD, Eric Jourdan, MD PhD, Alessandro M. Vannucchi, MD, Mark Drummond, MD PhD, Mindaugas Jurgutis, MD, Kazimierz Kuliczkowski, Professor, Emanuil Gheorghita, MD, Francesco Passamonti, MD, Frank Neumann, Florence Joulain, MSc, Sheikh Usman Iqbal, MD MPH MBA, Claire N Harrison, DM, FRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 4061.
https://doi.org/10.1182/blood.V122.21.4061.4061
Published: 2013
Journal Articles

Characteristics Of Patients Included In The Myelofibrosis Real-World Practice-Based Network Research (ENRiCH) Data Platform

Gregory Hess, Eileen Fonseca, Andrew Lee, Hongwei Wang, Ravinder Dhawan, Stephen F Thompson, Sheikh Usman Iqbal, Sean Redmond
Journal: Blood
Blood (2013) 122 (21): 1580.
https://doi.org/10.1182/blood.V122.21.1580.1580
Published: 2013
Journal Articles

Ruxolitinib Discontinuation In Patients With Myelofibrosis: An Analysis From Clinical Practice

Eileen Fonseca, Richard T. Silver, Lewis E. Kazis, Sheikh Usman Iqbal, Mathieu Rose, Nasreen Khan
Journal: Blood
Blood (2013) 122 (21): 2833.
https://doi.org/10.1182/blood.V122.21.2833.2833
Published: 2013